Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
2.
Mol Neurobiol ; 60(6): 3496-3506, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36879138

ABSTRACT

Movement disorder (MD) is an important manifestation of neurologic Wilson disease (NWD), but there is a paucity of information on dopaminergic pathways. We evaluate dopamine and its receptors in patients with NWD and correlate the changes with MD and MRI changes. Twenty patients with NWD having MD were included. The severity of dystonia was assessed using BFM (Burke-Fahn-Marsden) score. The neurological severity of NWD was categorized as grades I to III based on the sum score of 5 neurological signs and activity of daily living. Dopamine concentration in plasma and CSF was measured using liquid chromatography-mass spectrometry, and D1 and D2 receptor expression at mRNA by reverse transcriptase polymerase chain reaction in patients and 20 matched controls. The median age of the patients was 15 years and 7 (35%) were females. Eighteen (90%) patients had dystonia and 2 (10%) had chorea. The CSF dopamine concentration (0.08 ± 0.02 vs 0.09 ± 0.017 pg/ml; p = 0.42) in the patients and controls was comparable, but D2 receptor expression was reduced in the patients (0.41 ± 0.13 vs 1.39 ± 1.04; p = 0.01). Plasma dopamine level correlated with BFM score (r = 0.592, p < 0.01) and D2 receptor expression with the severity of chorea (r = 0.447, p < 0.05). The neurological severity of WD correlated with plasma dopamine concentration (p = 0.006). Dopamine and its receptors were not related to MRI changes. The central nervous system dopaminergic pathway is not enhanced in NWD, which may be due to structural damage to the corpus striatum and/or substantia nigra.


Subject(s)
Chorea , Dystonia , Hepatolenticular Degeneration , Movement Disorders , Female , Humans , Adolescent , Male , Dopamine/metabolism , Hepatolenticular Degeneration/metabolism , Dystonia/metabolism , Chorea/metabolism , Receptors, Dopamine D2/metabolism , Corpus Striatum/metabolism , Receptors, Dopamine D1/metabolism , Substantia Nigra/metabolism , Carrier Proteins/metabolism
3.
Zootaxa ; 5155(4): 539-548, 2022 Jun 23.
Article in English | MEDLINE | ID: mdl-36095569

ABSTRACT

A host association for Syncola crypsimorpha (Meyrick, 1922) is discovered after 100 years, since its original description. In India, two blastobasid species, Syncola crypsimorpha (Meyrick, 1922) and S. pulverea (Meyrick, 1907) (Lepidoptera: Gelechioidea), are predators of cultured lac, Kerria lacca (Kerr, 1782) (Hemiptera: Kerridae). Descriptions, diagnoses, and images and illustrations of the adult stage, including the male and female genitalia, for these two species are provided to facilitate identifications. A lectotype for Syncola crypsimorpha is designated herein.


Subject(s)
Hemiptera , Moths , Animals , Female , India , Male
4.
Am J Trop Med Hyg ; 2022 05 09.
Article in English | MEDLINE | ID: mdl-35533695

ABSTRACT

Adult-onset subacute sclerosing panencephalitis (SSPE) is rare, and focal myoclonus as a presenting feature poses a diagnostic dilemma. We report an adult SSPE patient with unusual clinical and radiological features. A 20-year-old girl had jerky neck movement 9 months earlier, which progressed to left hemimyoclonus in 2 months and generalized frequent myoclonus and fall at 4 months. By 6 months, she was bedbound. On examination, her Mini-Mental State Examination score was 10, and patchy retinitis was observed around the macula. Magnetic resonance imaging revealed corpus striatal involvement and electroencephalography showed periodic discharges. Measles cerebrospinal fluid/serum immunoglobulin G index was 3.3 (normal < 1.3), confirming the diagnosis of SSPE. SSPE should also be considered in adults having focal myoclonus with corpus striatal lesion. EEG is helpful in the diagnosis.

5.
BMJ Case Rep ; 15(4)2022 Apr 01.
Article in English | MEDLINE | ID: mdl-35365469

ABSTRACT

Vitellointestinal duct anomalies, although one of the most frequent malformations to be found (2%-3% in population), they are most unlikely to cause symptoms. A persistent Vitellointestinal duct can induce abdominal pain, bowel obstruction, intestinal haemorrhage and umbilical sinus, fistula or hernia which commonly occurs in children. Patent vitellointestinal duct or persistent omphalomesenteric duct is a very unusual congenital anomaly which occurs in 2% of the population related to the embryonic yolk stalk. Similarly, urachal anomalies remain a rare finding, with the most common being a cyst or sinus followed by patent urachus and rarely a urachal diverticulum. Presenting symptoms include periumbilical discharge, pain and a palpable mass.Here, we report a case of an adult patient with patent vitellointestinal duct and urachus identified intraoperatively on diagnostic laparoscopy when being operated for umbilical hernia repair.


Subject(s)
Hernia, Umbilical , Intestinal Obstruction , Meckel Diverticulum , Urachus , Vitelline Duct , Adult , Child , Hernia, Umbilical/complications , Hernia, Umbilical/diagnosis , Hernia, Umbilical/surgery , Humans , Meckel Diverticulum/diagnosis , Meckel Diverticulum/diagnostic imaging , Urachus/abnormalities , Urachus/surgery , Vitelline Duct/abnormalities
6.
Heliyon ; 7(1): e06044, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33553738

ABSTRACT

1H as well as 13C chemical shifts of 32 compounds of C (3) substituted 2-(n-alkylamino)-3R-naphthalene-1,4-dione (where n-alkyl: methyl, to octyl, R = H, Cl, Br, and CH3) are investigated through 1H, 13C, DEPT, gDQCOSY, and gHSQCAD NMR experiments and M06-2X/6-311++G (d,p) density functional theory are discussed. Single crystal X-ray structure of Br-3, as well as 18 different derivatives of naphthalene-1,4-diones, are revealed for its inter and intra-molecular hydrogen bonding interactions.

7.
Trans R Soc Trop Med Hyg ; 115(9): 1091-1093, 2021 09 03.
Article in English | MEDLINE | ID: mdl-33515451

ABSTRACT

BACKGROUND: Scrub typhus is prevalent in the Tsutsugamushi belt and may manifest with meningoencephalitis and seizures. We report a patient with scrub typhus who had non-convulsive status epilepticus (NCSE). METHODS: A 50-y-old female with fever and altered sensorium for 5 d was diagnosed as scrub typhus based on serum IgM ELISA. She was on mechanical ventilation and received doxycycline and ceftriaxone, but did not improve until the third day of admission. RESULTS: An EEG revealed >2.5 Hz generalised epileptiform discharges, which were suppressed by intravenous lorazepam suggesting NCSE. Following valproate and levetiracetam, she became conscious and had a full recovery. CONCLUSION: A scrub typhus patient recovers even after prolonged NCSE.


Subject(s)
Orientia tsutsugamushi , Scrub Typhus , Status Epilepticus , Coma/etiology , Doxycycline/therapeutic use , Female , Humans , Scrub Typhus/complications , Scrub Typhus/diagnosis , Scrub Typhus/drug therapy , Seizures , Status Epilepticus/diagnosis , Status Epilepticus/drug therapy , Status Epilepticus/etiology
8.
Int Immunopharmacol ; 33: 63-9, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26869203

ABSTRACT

Rheumatoid arthritis (RA), an autoimmune-inflammatory disease is characterized by dysregulation of signal transduction pathways, increased production of pro-inflammatory cytokines, enhanced leukocyte infiltration into synovial microvascular endothelium, extensive formation of hyper proliferative pannus, degradation of cartilage and bone erosion. Several compounds that abrogate cytokine production demonstrate a therapeutic effect in experimental models of arthritis. In this study, we report that a novel semi-synthetic natural product (Compound A) being a preferential IL-6 inhibitor, is efficacious in a murine model of arthritis. In vitro evaluations of pro-inflammatory cytokine production reveal that Compound A preferentially inhibits induced production of IL-6 and not TNF-α from THP-1 cells and isolated human monocytes. Furthermore, Compound A robustly inhibits the spontaneous production of IL-6 from pathologically relevant synovial tissue cells isolated from patients with active RA. In a physiologically relevant assay, Compound A selectively inhibits the activated T cell contact-mediated production of IL-6 from human monocytes. Compound A, at pharmacologically efficacious concentrations, does not significantly curtail the LPS-induced activation of p38 MAPKs. In the collagen-induced arthritis (CIA) mouse model (i) macroscopic observations demonstrate that Compound A, administered subcutaneously in a therapeutic regimen, significantly and dose-dependently inhibits disease associated increases in articular index and paw thickness; (ii) histological analyses of paw tissues reveal that Compound A prominently diminishes joint destruction, hyperproliferative pannus formation and infiltration of inflammatory cells. Collectively, these results provide direct evidence that Compound A, a novel preferential IL-6 inhibitor, suppresses collagen-induced arthritis, and may be a potential therapeutic for treating patients with active RA.


Subject(s)
Actinobacteria/immunology , Antirheumatic Agents/therapeutic use , Arthritis, Experimental/drug therapy , Arthritis, Rheumatoid/drug therapy , Interleukin-6/antagonists & inhibitors , Monocytes/drug effects , Polyenes/therapeutic use , Animals , Cell Line , Disease Models, Animal , Humans , Male , Mice , Mice, Inbred DBA , Monocytes/immunology , Polyenes/chemical synthesis
9.
J Stem Cells ; 7(3): 127-53, 2012.
Article in English | MEDLINE | ID: mdl-23619381

ABSTRACT

The two neighboring southwestern states of India, Karnataka and Maharashtra, have high incidence of HIV/AIDS and are among the six most high prevalence HIV infected states. In Karnataka state, the northern districts of Bagalkot, Belgaum and Bijapur (the three Bs) and in Maharashtra state, the southern districts of Sangli, Satara, and Solapur (the three Ss) are the areas with the highest incidence of HIV/AIDS. We have evaluated the incidence of maternal to child transmission (MTCT) of HIV-1 infection in Belgaum District which is more than 500 kilometers distance by road from the campus in greater Bangalore (Karnataka State). We have obtained the prenatal CD4 counts of HIV infected pregnant mothers. We have also screened the HIV infected children in two orphanages (rehabilitation centres for HIV infected children) in Belgaum District. The clinical conditions of these infected children were assessed for their CD4 counts, anti-retroviral therapy (ART) intake status, outpatient illnesses and body composition. We have observed that there is an influence of the age factor on the CD4 counts of the HIV infected children. Further, in view of the role of our recently found involvement of sulfatide, 3-O- galactosylceramide, in inhibition of HIV-1 replication and enhancement of hematopoiesis which is otherwise inhibited due to such infection, we have discussed the possible role of sulfatides that biologically occur in the fetal adnexa (placentatrophoblasts /amnion/chorion-umbilical cord), in containing HIV infection as a potential safer alternative to the ART regimens currently approved to be clinically practiced. Lastly, we have discussed the complementary and alternative medicine (CAM) therapies such as evidence based yoga and ayurveda as add-on to ART in potential elimination of MTCT of HIV infection. Out of a total of 150 children delivered by HIV infected mothers, 13 children were found to be positive as determined by the dried blood smear (DBS) for virological testing, giving an incidence of about 8.66% in the Belgaum district during the last two years, in spite of the prescription of currently available ART regimens. All the 13 HIV-transmitting mothers had normal vaginal deliveries. Though 12% of the total 150 deliveries required lower segment caesarean section (LSCS), none among them resulted in MTCT of HIV. Comparison of the prenatal CD4 counts between transmitting and non-transmitting mothers did not show significant differences (p=0.25) thus suggesting indirectly that HIV-1 proviral loads (undetermined / unavailable) need not necessarily determine the fate of incidence of vertical transmission. The mean age of 44 HIV infected children (14 females, 30 males) that were screened in two orphanages was 10.8±3.1 years. Out of these 44 children, 27 were taking ART (61.36%) with mean duration of consumption being 2.8±2.28 years. Fifty percent (n=22) of the children were suffering from at least one outpatient illness, out of which 13 were taking ART. Their mean basal metabolic rate (BMR), body mass index (BMI), muscle mass, fat mass and fat % were 795.45±106.9, 14.55±1.9 kg/m(2), 9.54±3.4 kg, 3.69±2.24 kg and 15.04±7.8% respectively. Comparison between the children taking ART (on-ART, n=27) and those not taking ART (non-ART, n= 17) showed that though there was no significant difference in the average age of the two groups, on-ART children had significantly higher BMR (p=0.05), and muscle mass (p=0.004), than non-ART. The CD4 counts, BMI, fat mass and fat percentage did not show significant statistical differences between the two groups. The CD4 counts of the children (both on-ART and non-ART) of age 8 years and below (n=12) were found to be significantly higher (p=0.04) than those of age 14 and above (n=10). All the children in age group of 14 years and above (n=10) except one child were on ART, whereas 7 out of 12 children in age group of 8 years and below were on-ART. In one of the rehabilitation centers called Aadhar, among non-ART children, a significant correlation was observed between the age of the child and CD4 counts (measured separately in the months of June 2011 and December 2011). Both the CD4 counts measured in June 2011 (n=6; r=-0.82, p= 0.04) as well as in December 2011 (n=6; r=-0.97, p=0.001) showed a significant decline as the age progressed. Also, at the same center, among on-ART children, the CD4 counts in June 2011 (n=7) and December 2011 (n=8) were significantly different between the children in the age group of 8 below years, and those in the age group of 14 years and above (p= 0.005). As HIV infected children grow in age, they may lose maternal derived immunity as shown by the decrease in CD4 counts, irrespective of their ART status. It is to be expected from these results that the conferred maternal immunity (possibly primarily humoral and secondarily cytotoxic immune responses) to the virus acquired at child birth taper off and eventually overcome by the generation of mutant HIV strains in the children, as the life spans of the infected children progress. We have discussed safer therapeutic interventions whose efficacy on HIV/AIDS may be synergistic to or even substitute the existing treatment strategies. Some of such interventions may even be customized to help eliminate MTCT. Further, these virus infected pregnant mother patient blood / serum samples could prove useful in the vaccine development against HIV infection.


Subject(s)
Anti-Retroviral Agents/therapeutic use , Complementary Therapies , HIV Infections/transmission , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious/virology , Sulfoglycosphingolipids/therapeutic use , Adolescent , Adult , Age Factors , Amnion/immunology , Amnion/metabolism , Amnion/virology , CD4 Lymphocyte Count , Child , Child, Preschool , Chorion/immunology , Chorion/metabolism , Chorion/virology , Female , HIV Infections/drug therapy , HIV Infections/immunology , HIV-1/drug effects , HIV-1/isolation & purification , Humans , India , Infant , Male , Mothers , Placenta/immunology , Placenta/metabolism , Placenta/virology , Pregnancy , Pregnancy Complications, Infectious/immunology , Umbilical Cord/immunology , Umbilical Cord/metabolism , Umbilical Cord/virology , Viral Load
10.
Am J Physiol Cell Physiol ; 298(4): C929-41, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20089935

ABSTRACT

A promising therapeutic approach to diminish pathological inflammation is to inhibit the increased production and/or biological activity of proinflammatory cytokines (e.g., TNF-alpha, IL-6). The production of proinflammatory cytokines is controlled at the gene level by the activity of transcription factors, such as NF-kappaB. Phosphatidylinositol 3-kinase (PI3K), a lipid kinase, is known to induce the activation of NF-kappaB. Given this, we hypothesized that inhibitors of PI3K activation would demonstrate anti-inflammatory potential. Accordingly, we studied the effects of a preferential p110alpha/gamma PI3K inhibitor (compound 8C; PIK-75) in inflammation-based assays. Mechanism-based assays utilizing human cells revealed that PIK-75-mediated inhibition of PI3K activation is associated with dramatic suppression of downstream signaling events, including AKT phosphorylation, IKK activation, and NF-kappaB transcription. Cell-based assays revealed that PIK-75 potently and dose dependently inhibits in vitro and in vivo production of TNF-alpha and IL-6, diminishes the induced expression of human endothelial cell adhesion molecules (E-selectin, ICAM-1, and VCAM-1), and blocks human monocyte-endothelial cell adhesion. Most importantly, PIK-75, when administered orally in a therapeutic regimen, significantly suppresses the macroscopic and histological abnormalities associated with dextran sulfate sodium-induced murine colitis. The efficacy of PIK-75 in attenuating experimental inflammation is mediated, at least in part, due to the downregulation of pertinent inflammatory mediators in the colon. Collectively, these results provide first evidence that PIK-75 possesses anti-inflammatory potential. Given that PIK-75 is known to exhibit anti-cancer activity, the findings from this study thus reinforce the cross-therapeutic functionality of potential drugs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Enzyme Inhibitors/pharmacology , Hydrazones/pharmacology , Inflammation Mediators/metabolism , Inflammation/metabolism , NF-kappa B/metabolism , Phosphoinositide-3 Kinase Inhibitors , Protein Subunits/antagonists & inhibitors , Sulfonamides/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cell Adhesion , Cell Line , Colitis/drug therapy , Colitis/immunology , E-Selectin/metabolism , Endothelial Cells/cytology , Endothelial Cells/metabolism , Enzyme Activation , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/therapeutic use , Humans , Hydrazones/metabolism , Hydrazones/toxicity , I-kappa B Kinase/metabolism , Inflammation/drug therapy , Intercellular Adhesion Molecule-1/metabolism , Interleukin-6/antagonists & inhibitors , Mice , Mice, Inbred BALB C , Molecular Structure , Monocytes/cytology , Monocytes/metabolism , NF-kappa B/genetics , Phosphatidylinositol 3-Kinases/metabolism , Protein Subunits/metabolism , Signal Transduction , Sulfonamides/metabolism , Sulfonamides/toxicity , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Vascular Cell Adhesion Molecule-1/metabolism
11.
Bioorg Med Chem Lett ; 19(11): 2949-52, 2009 Jun 01.
Article in English | MEDLINE | ID: mdl-19409777

ABSTRACT

A series of novel cyanopyridyl based molecules (1-14) were designed, synthesized and probed for inhibition of mammalian target of rapamycin (mTOR) activity. Compound 14 was found to be a potent inhibitor of mTOR activity as assessed by enzyme-linked immunoassays and Western blot analysis. Most importantly, systemic application (intraperitoneal; ip) of compound 14 significantly suppressed macroscopic and histological abnormalities associated with chemically-induced murine colitis.


Subject(s)
Nitriles/chemical synthesis , Protein Kinase Inhibitors/chemical synthesis , Protein Kinases/metabolism , Pyridines/chemical synthesis , Acrylamides/chemical synthesis , Acrylamides/pharmacokinetics , Acrylamides/therapeutic use , Animals , Cell Line, Tumor , Colitis, Ulcerative/chemically induced , Colitis, Ulcerative/drug therapy , Disease Models, Animal , Humans , Mice , Nitriles/chemistry , Nitriles/pharmacokinetics , Protein Kinase Inhibitors/pharmacokinetics , Protein Kinase Inhibitors/therapeutic use , Protein Kinases/chemistry , Pyridines/pharmacokinetics , Pyridines/therapeutic use , TOR Serine-Threonine Kinases
12.
Am J Physiol Gastrointest Liver Physiol ; 295(6): G1237-45, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18927209

ABSTRACT

Ulcerative colitis is an autoimmune-inflammatory disease characterized by increased proliferation of colonic epithelial cells, dysregulation of signal transduction pathways, elevated mucosal T cell activation, increased production of proinflammatory cytokines, and enhanced leukocyte infiltration into colonic interstitium. Several compounds that possess antiproliferative properties and/or inhibit cytokine production exhibit a therapeutic effect in murine models of colitis. Mammalian target of rapamycin (mTOR), a protein kinase regulating cell proliferation, is implicated in colon carcinogenesis. In this study, we report that a novel haloacyl aminopyridine-based molecule (P2281) is a mTOR inhibitor and is efficacious in a murine model of human colitis. In vitro studies using Western blot analysis and cell-based ELISA assays showed that P2281 inhibits mTOR activity in colon cancer cells. In vitro and in vivo assays of proinflammatory cytokine production revealed that P2281 diminishes induced IFN-gamma production but not TNF-alpha production, indicating preferential inhibitory effects of P2281 on T cell function. In the dextran sulfate sodium (DSS) model of colitis, 1) macroscopic colon observations demonstrated that P2281 significantly inhibited DSS-induced weight loss, improved rectal bleeding index, decreased disease activity index, and reversed DSS-induced shortening of the colon; 2) histological analyses of colonic tissues revealed that P2281 distinctly attenuated DSS-induced edema, prominently diminished the leukocyte infiltration in the colonic mucosa, and resulted in protection against DSS-induced crypt damage; and 3) Western blot analysis showed that P2281 blocks DSS-induced activation of mTOR. Collectively, these results provide direct evidence that P2281, a novel mTOR inhibitor, suppresses DSS-induced colitis by inhibiting T cell function and is a potential therapeutic for colitis. Given that compounds with anticancer activity show promising anti-inflammatory efficacy, our findings reinforce the cross-therapeutic functionality of potential drugs.


Subject(s)
Aminopyridines/therapeutic use , Anilides/therapeutic use , Carrier Proteins/antagonists & inhibitors , Colitis/drug therapy , Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors , Animals , Cell Line, Tumor , Colitis/chemically induced , Dextran Sulfate , Disease Models, Animal , Humans , Interferon-gamma/antagonists & inhibitors , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , TOR Serine-Threonine Kinases , Tumor Necrosis Factor-alpha/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...